Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?
Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, WC1N 3BG, UK. Electronic address: andreas.charidimou.09@ucl.ac.uk.
Andreas
A
Charidimou
Lysholm Department of Neuroradiology, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK; Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK.
Hans Rolf J
HR
Jäger
D015415:Biomarkers; D016657:Cerebral Amyloid Angiopathy / Q000473:pathology* / Q000628:therapy*; D006801:Humans
D015415:Biomarkers